Bruno Medeiros
Publications
- Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia. Haematologica. 2013; (4): 591-6
- Blood consult: monosomal karyotype acute myeloid leukemia. Blood. 2012; (24): 5659-60
- Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica. 2012; (9): 1401-4
- Impact of residual normal metaphases in core binding factor acute myeloid leukemia. Cancer. 2012; (9): 2420-3
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia. Leukemia. 2012; (5): 893-901
- Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia. Am J Hematol. 2012; (1): 45-50
- Unveiling the complexity of CK+ AML. Blood. 2012; (9): 1958-9
- Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011; (22): 2167-8; author reply 2168-9
- Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood. 2010; (13): 2224-8
- 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. Leuk Lymphoma. 2013; (2): 408-10
- A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia. Leuk Lymphoma. 2013
- CD11b expression and MK+ AML: a sign of impending doom? Leuk Res. 2013; (2): 121
- "It doesn't matter if you're black or white", does it? Leuk Res. 2012; (2): 127
- Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma? Appl Immunohistochem Mol Morphol. 2012; (3): 325-30
- CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. Leukemia. 2012; (12): 2530-7
- Novel agents in acute myeloid leukemia. Int J Hematol. 2012; (2): 178-85
- Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Haematologica. 2012; (1): 30-7
- Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia. Haematologica. 2012; (5): 739-42
- Treatment advances have not improved the early death rate in acute promyelocytic leukemia. Haematologica. 2012; (1): 133-6
- Acute myeloid leukaemia in the elderly: a review. Br J Haematol. 2011; (5): 524-42
- Microfluidic purification and analysis of hematopoietic stem cells from bone marrow. Lab Chip. 2011; (18): 3130-5
- Unfavorable-risk cytogenetics in acute myeloid leukemia. Expert Rev Hematol. 2011; (2): 173-84
- Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Leuk Res. 2010; (5): 594-7
- Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol. 2010; (8): 600-6
- Plasma cell leukemia: concepts and management. Expert Rev Hematol. 2010; (5): 543-9
- Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience. Am J Hematol. 2010; (11): 877-81
- Comparing apples and oranges in normal karyotype acute myeloid leukemia. J Clin Oncol. 2009; (3): 474; author reply 474-6
- Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report. Cases J. 2009; (1): 121
- Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med. 2009; (17): 1787; author reply 1787-8
- Role of CEBPA in normal karyotype acute myeloid leukemia. J Clin Oncol. 2009; (12): 2105; author reply 2106
- Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy. Am J Hematol. 2009; (10): 698-9
Help
Trial Administration